Cite
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence
MLA
David Bakhshinyan, et al. “Temporal Profiling of Therapy Resistance in Human Medulloblastoma Identifies Novel Targetable Drivers of Recurrence.” Science Advances, vol. 7, no. 50, Dec. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2ff934887f48ef8f639df88ddc2b49cd&authtype=sso&custid=ns315887.
APA
David Bakhshinyan, Ashley A. Adile, Jeff Liu, William D. Gwynne, Yujin Suk, Stefan Custers, Ian Burns, Mohini Singh, Nicole McFarlane, Minomi K. Subapanditha, Maleeha A. Qazi, Parvez Vora, Michelle M. Kameda-Smith, Neil Savage, Kim L. Desmond, Nazanin Tatari, Damian Tran, Mathieu Seyfrid, Kristin Hope, … Sheila K. Singh. (2021). Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence. Science Advances, 7(50).
Chicago
David Bakhshinyan, Ashley A. Adile, Jeff Liu, William D. Gwynne, Yujin Suk, Stefan Custers, Ian Burns, et al. 2021. “Temporal Profiling of Therapy Resistance in Human Medulloblastoma Identifies Novel Targetable Drivers of Recurrence.” Science Advances 7 (50). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2ff934887f48ef8f639df88ddc2b49cd&authtype=sso&custid=ns315887.